Pfizer sued over poultry feed additive

20-10-2011 | | |
Pfizer sued over poultry feed additive

Zhejiang Rongyao Chemical has filed a lawsuit against Pfizer claiming a breach of contract to purchase Roxarsone, the active ingredient in 3-Nitro, a veterinary product used primarily in the treatment of coccidiosis in poultry.

Alpharma of Bridgewater, NJ, now a part of Pfizer Animal Health, had an exclusive multi-year agreement to purchase Roxarsone/3-Nitro from Rongyao, but voluntarily suspended sales of the product after a meeting with the US Food and Drug Administration (FDA).

Alpharma had been a distributor of 3-Nitro for many years. In June 2011, sales abruptly stopped when Pfizer voluntarily halted distribution following a report by the FDA that allegedly found high levels of inorganic arsenic in the livers of treated chickens. At the time of the decision to halt the distribution, both Pfizer and the FDA had stressed that 3-Nitro did not pose an imminent public health risk and that there was no need for people to alter their chicken consumption.

3-Nitro has been used in chicken feed for over fifty years. According to Dr. Rener Chen, Rongyao’s General Manager, “The FDA’s study was incomplete, non-peer reviewed and the results, therefore, are flawed. Further expert scientific review has found it inconclusive due to various inconsistencies.”
As a result of Pfizer’s actions, effectively cancelling a multi-year deal struck in January 2011, Rongyao can no longer sell Roxarsone/3-Nitro in the US, Canada and a number of other markets, resulting in more than twenty million dollars in losses for Rongyao.

Dr. Chen further stated that, “The timing of Pfizer’s decision to voluntarily suspend its sales of 3-Nitro, under the veil of the FDA study and the associated FDA pressure, is suspect as it comes at the same time as reports in the industry that Pfizer is looking to completely sell off all of its Animal Health division and remove itself from this market altogether.”

Rongyao has requested judgment in its favor for all compensatory damages, including but not limited to lost profits, plus interest, attorneys’ fees, and further relief that the Court deems just and proper. The filing was made in US District Court for the District of New Jersey on October 3, 2011.

Join 31,000+ subscribers

Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.